Cargando…
Syndecan-1 regulates α(v)β(3) and α(v)β(5) integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
Syndecan-1 (Sdc1) is a matrix receptor shown to associate via its extracellular domain with the α(v)β(3) and α(v)β(5) integrins, potentially regulating cell adhesion, spreading, and invasion of cells expressing these integrins. Using Sdc1 deletion mutants expressed in human mammary carcinoma cells,...
Autores principales: | Beauvais, DeannaLee M., Ell, Brian J., McWhorter, Andrea R., Rapraeger, Alan C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699122/ https://www.ncbi.nlm.nih.gov/pubmed/19255147 http://dx.doi.org/10.1084/jem.20081278 |
Ejemplares similares
-
The syndecan-1 ectodomain regulates α(v)β(3) integrin activity in human mammary carcinoma cells
por: Beauvais, DeannaLee M., et al.
Publicado: (2004) -
Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004) -
Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface
por: Rapraeger, Alan C.
Publicado: (2021) -
Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression
por: Beauvais, DeannaLee M., et al.
Publicado: (2022) -
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
por: Jung, O, et al.
Publicado: (2016)